Loomis, Sayles & Company’s Omega Healthcare OHI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $37.5K | Hold |
786
| – | – | ﹤0.01% | 649 |
|
|
2026
Q1 | $34.4K | Hold |
786
| – | – | ﹤0.01% | 634 |
|
|
2025
Q4 | $34.9K | Hold |
786
| – | – | ﹤0.01% | 638 |
|
|
2025
Q3 | $33.2K | Sell |
786
-94
| -11% | -$3.79K | ﹤0.01% | 650 |
|
|
2025
Q2 | $32.3K | Sell |
880
-7
| -0.8% | -$260 | ﹤0.01% | 662 |
|
|
2025
Q1 | $34K | Sell |
887
-588
| -40% | -$21.9K | ﹤0.01% | 675 |
|
|
2024
Q4 | $56K | Buy |
1,475
+319
| +28% | +$12.7K | ﹤0.01% | 648 |
|
|
2024
Q3 | $47K | Buy |
+1,156
| New | +$43.7K | ﹤0.01% | 640 |
|
|
2022
Q1 | – | Sell |
-39,455
| Closed | -$1.17M | – | 1036 |
|
|
2021
Q4 | $1.17M | Sell |
39,455
-11,841
| -23% | -$346K | ﹤0.01% | 497 |
|
|
2021
Q3 | $1.54M | Buy |
51,296
+3,530
| +7% | +$121K | ﹤0.01% | 490 |
|
|
2021
Q2 | $1.73M | Buy |
47,766
+47,683
| +57,449% | +$1.77M | ﹤0.01% | 472 |
|
|
2021
Q1 | $3K | Buy |
+83
| New | +$3.06K | ﹤0.01% | 828 |
|
|
2019
Q4 | – | Sell |
-370
| Closed | -$15K | – | 756 |
|
|
2019
Q3 | $15K | Hold |
370
| – | – | ﹤0.01% | 693 |
|
|
2019
Q2 | $14K | Hold |
370
| – | – | ﹤0.01% | 550 |
|
|
2019
Q1 | $14K | Sell |
370
-477
| -56% | -$17.7K | ﹤0.01% | 698 |
|
|
2018
Q4 | $30K | Sell |
847
-146
| -15% | -$5.06K | ﹤0.01% | 624 |
|
|
2018
Q3 | $33K | Sell |
993
-94
| -9% | -$2.99K | ﹤0.01% | 653 |
|
|
2018
Q2 | $34K | Sell |
1,087
-58
| -5% | -$1.66K | ﹤0.01% | 677 |
|
|
2018
Q1 | $31K | Buy |
+1,145
| New | +$30.5K | ﹤0.01% | 697 |
|
|
2017
Q4 | – | Sell |
-324,040
| Closed | -$10.3M | – | 913 |
|
|
2017
Q3 | $10.3M | Sell |
324,040
-29,390
| -8% | -$942K | 0.02% | 420 |
|
|
2017
Q2 | $11.7M | Sell |
353,430
-24,912
| -7% | -$824K | 0.03% | 385 |
|
|
2017
Q1 | $12.5M | Sell |
378,342
-185,940
| -33% | -$5.97M | 0.03% | 370 |
|
|
2016
Q4 | $17.6M | Sell |
564,282
-110,758
| -16% | -$3.42M | 0.04% | 300 |
|
|
2016
Q3 | $23.9M | Sell |
675,040
-11,529
| -2% | -$410K | 0.06% | 210 |
|
|
2016
Q2 | $23.3M | Buy |
686,569
+150,306
| +28% | +$5.02M | 0.06% | 228 |
|
|
2016
Q1 | $18.9M | Buy |
536,263
+314,305
| +142% | +$10.3M | 0.05% | 285 |
|
|
2015
Q4 | $7.76M | Sell |
221,958
-3,811
| -2% | -$132K | 0.02% | 457 |
|
|
2015
Q3 | $7.94M | Hold |
225,769
| – | – | 0.02% | 448 |
|
|
2015
Q2 | $7.75M | Sell |
225,769
-93,162
| -29% | -$3.42M | 0.02% | 490 |
|
|
2015
Q1 | $12.9M | Sell |
318,931
-27,473
| -8% | -$1.14M | 0.04% | 445 |
|
|
2014
Q4 | $13.5M | Sell |
346,404
-142,286
| -29% | -$5.39M | 0.04% | 454 |
|
|
2014
Q3 | $16.7M | Sell |
488,690
-5,660
| -1% | -$208K | 0.05% | 383 |
|
|
2014
Q2 | $18.2M | Sell |
494,350
-75,595
| -13% | -$2.7M | 0.05% | 384 |
|
|
2014
Q1 | $19.1M | Sell |
569,945
-15,444
| -3% | -$492K | 0.05% | 368 |
|
|
2013
Q4 | $17.4M | Sell |
585,389
-2,215
| -0.4% | -$70.2K | 0.05% | 404 |
|
|
2013
Q3 | $17.6M | Sell |
587,604
-2,489
| -0.4% | -$75.7K | 0.06% | 377 |
|
|
2013
Q2 | $18.3M | Buy |
+590,093
| New | +$19.4M | 0.07% | 327 |
|
Other funds holding OHI
Loomis, Sayles & Company's OHI Position: Q2 2026 in Review
Loomis, Sayles & Company held its Omega Healthcare (OHI) position steady in Q2 2026 at 786 shares worth $37.5K. The position accounts for ﹤0.01% of the portfolio, ranked #649.
Loomis, Sayles & Company first reported a position in OHI in Q2 2013 and has held it in 37 quarters since. The position peaked at $23.9M in Q3 2016. 759 funds tracked by Wall St. Rank hold OHI as of Q2 2026.
- Loomis, Sayles & Company held 786 shares of Omega Healthcare worth $37.5K as of Q2 2026.
- Loomis, Sayles & Company left its Omega Healthcare share count unchanged in Q2 2026.
- Omega Healthcare made up ﹤0.01% of Loomis, Sayles & Company's portfolio in Q2 2026, its #649 holding.
- Loomis, Sayles & Company first reported a position in Omega Healthcare in Q2 2013 and has held it in 37 quarters since.
- Loomis, Sayles & Company's Omega Healthcare position peaked at $23.9M in Q3 2016.
- 759 funds tracked by Wall St. Rank held Omega Healthcare as of Q2 2026.
Based on Loomis, Sayles & Company's 13F filing for Q2 2026, filed 14 Aug 2026.